Home › Funds › Alphabet Inc. › GLUE

Alphabet Inc. position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

Alphabet Inc. reported holding 372,474 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.01% of its reported portfolio and ranking #26 among its reported holdings. Alphabet Inc. has disclosed GLUE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)372.47K sh
Reported value held$4.44M
Portfolio Weight0.01%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Alphabet Inc.'s GLUE position evolved

Alphabet Inc. first disclosed a stake in GLUE in Q3 2023 at 1,464,015 shares (US$7.0M). The position peaked in Q4 2025 at 744,948 shares, worth US$11.7M. Across 13 filings, Alphabet Inc. increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 372,474 shares valued at US$4.4M. Notable position changes include a 49% trim in Q4 2025 (shares rose 5% over the following quarter), a 46% trim in Q2 2026 (shares fell 51% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.46M $7.01M New
Q4 2023 1.46M $8.27M Hold
Q1 2024 1.46M $10.32M Hold
Q2 2024 1.46M $5.48M Hold
Q3 2024 1.46M $7.76M Hold
Q4 2024 1.46M $10.16M Hold
Q1 2025 1.46M $6.79M Hold
Q2 2025 1.46M $6.60M Hold
Q3 2025 1.46M $10.85M Hold
Q4 2025 744.95K $11.68M Reduce
Q1 2026 684.27K $11.26M Reduce
Q2 2026 372.47K $9.01M Reduce
Q3 2026 372.47K $4.44M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 65 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has Alphabet Inc. held GLUE?

Alphabet Inc. has disclosed GLUE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Alphabet Inc.'s current position in GLUE?

As of Q3 2026, Alphabet Inc. holds 372.47K shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $4.44M, representing 0.01% of its reported portfolio and ranking #26.

Has Alphabet Inc. been buying or selling GLUE?

In the latest 13F filing (Q3 2026), Alphabet Inc. held unchanged its position in GLUE. The position peaked in Q4 2025 at 744.95K shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 65 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.